OncoMed Pharmaceuticals Inc Net Cash Provided by (Used in) Operating Activities, Continuing Operations
OncoMed Pharmaceuticals Inc reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$14.40 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2018-05-08
- OncoMed Pharmaceuticals Inc net cash provided by (used in) operating activities, continuing operations for the quarter ending 2018-03-31 was -$14.40M.
- OncoMed Pharmaceuticals Inc net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-12-31 was -$12.35M.
- OncoMed Pharmaceuticals Inc net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-09-30 was -$16.53M.
- OncoMed Pharmaceuticals Inc net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-06-30 was -$27.11M.
- OncoMed Pharmaceuticals Inc net cash provided by (used in) operating activities, continuing operations for fiscal 2017 was -$84.97M.
- OncoMed Pharmaceuticals Inc net cash provided by (used in) operating activities, continuing operations for fiscal 2016 was -$36.94M.
- OncoMed Pharmaceuticals Inc net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was -$75.14M.
- OncoMed Pharmaceuticals Inc net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was -$84.50M, a 158.44% decline from fiscal 2013.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month as first filed | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month as first filed | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | -$14.40M 10-Q · filed 2018-05-08 | -$26.75M derived: sum of 2 quarters · filed 2018-05-08 | -$43.28M derived: sum of 3 quarters · filed 2018-05-08 | -$70.39M derived: sum of 4 quarters · filed 2018-05-08 | ||||
| 2017-12-31 | -$12.35M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$28.88M derived: sum of 2 quarters · filed 2018-03-09 | -$55.99M derived: sum of 3 quarters · filed 2018-03-09 | -$84.97M 10-K · filed 2018-03-09 | ||||
| 2017-09-30 | -$16.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$43.64M derived: sum of 2 quarters · filed 2017-11-02 | -$72.62M 10-Q · filed 2017-11-02 | -$95.47M derived: sum of 4 quarters · filed 2018-05-08 | ||||
| 2017-06-30 | -$27.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$56.09M 10-Q · filed 2017-08-02 | -$78.94M derived: sum of 3 quarters · filed 2018-05-08 | -$106.11M derived: sum of 4 quarters · filed 2018-05-08 | ||||
| 2017-03-31 | -$28.98M 10-Q · filed 2018-05-08 | -$51.83M derived: sum of 2 quarters · filed 2018-05-08 | -$79.00M derived: sum of 3 quarters · filed 2018-05-08 | -$101.80M derived: sum of 4 quarters · filed 2018-05-08 | ||||
| 2016-12-31 | -$22.85M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$50.02M derived: sum of 2 quarters · filed 2018-03-09 | -$72.82M derived: sum of 3 quarters · filed 2018-03-09 | -$36.94M 10-K · filed 2018-03-09 | ||||
| 2016-09-30 | -$27.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$49.97M derived: sum of 2 quarters · filed 2017-11-02 | -$14.09M 10-Q · filed 2017-11-02 | -$31.82M derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2016-06-30 | -$22.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $13.08M 10-Q · filed 2017-08-02 | -$4.64M derived: sum of 3 quarters · filed 2018-03-09 | -$30.07M derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2016-03-31 | $35.88M 10-Q · filed 2017-05-08 | $18.16M derived: sum of 2 quarters · filed 2018-03-09 | -$7.27M derived: sum of 3 quarters · filed 2018-03-09 | -$19.64M derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2015-12-31 | -$17.73M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$43.15M derived: sum of 2 quarters · filed 2018-03-09 | -$55.52M derived: sum of 3 quarters · filed 2018-03-09 | -$75.14M 10-K · filed 2018-03-09 | ||||
| 2015-09-30 | -$25.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | -$37.79M derived: sum of 2 quarters · filed 2016-11-01 | -$57.41M 10-Q · filed 2016-11-01 | -$57.54M 10-Q · filed 2015-11-05 | -$72.86M derived: sum of 4 quarters · filed 2017-03-09 | |||
| 2015-06-30 | -$12.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$31.99M 10-Q · filed 2016-08-09 | -$32.03M 10-Q · filed 2015-08-10 | -$47.44M derived: sum of 3 quarters · filed 2017-03-09 | -$66.31M derived: sum of 4 quarters · filed 2017-03-09 | |||
| 2015-03-31 | -$19.62M 10-Q · filed 2016-05-05 | -$19.64M 10-Q · filed 2015-05-07 | -$35.07M derived: sum of 2 quarters · filed 2017-03-09 | -$53.94M derived: sum of 3 quarters · filed 2017-03-09 | -$71.55M derived: sum of 4 quarters · filed 2017-03-09 | |||
| 2014-12-31 | -$15.45M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | -$34.33M derived: sum of 2 quarters · filed 2017-03-09 | -$51.93M derived: sum of 3 quarters · filed 2017-03-09 | -$84.50M 10-K · filed 2017-03-09 | -$84.51M 10-K · filed 2015-03-12 | |||
| 2014-09-30 | -$18.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$36.48M derived: sum of 2 quarters · filed 2015-11-05 | -$69.04M 10-Q · filed 2015-11-05 | $98.31M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-06-30 | -$17.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$50.17M 10-Q · filed 2015-08-10 | $117.18M derived: sum of 3 quarters · filed 2016-03-10 | $104.12M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-03-31 | -$32.57M 10-Q · filed 2015-05-07 | $134.78M derived: sum of 2 quarters · filed 2016-03-10 | $121.72M derived: sum of 3 quarters · filed 2016-03-10 | $117.98M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2013-12-31 | $167.35M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $154.29M derived: sum of 2 quarters · filed 2016-03-10 | $150.55M derived: sum of 3 quarters · filed 2016-03-10 | $144.59M 10-K · filed 2016-03-10 | $144.54M 10-K · filed 2015-03-12 | |||
| 2013-09-30 | -$13.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | -$16.80M derived: sum of 2 quarters · filed 2014-11-04 | -$22.75M 10-Q · filed 2014-11-04 | |||||
| 2013-06-30 | -$3.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$9.69M 10-Q · filed 2014-08-07 | ||||||
| 2013-03-31 | -$5.96M 10-Q · filed 2014-05-08 | |||||||
| 2012-12-31 | -$33.34M 10-K · filed 2015-03-12 |